Compugen CGEN
NASDAQ CGEN
$2.38 +0.03 (+1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Compugen (CGEN) Operating Interest Expenses (2011 - 2012)

Updated

Compugen's Operating Interest Expenses came in at -$1.53 million for Q4 2012, compared with -$1.32 million a year earlier.

Analysis

Compugen (CGEN) Operating Interest Expenses (2011 - 2012) Analysis & Trends

For FY2012, Compugen's Operating Interest Expenses was -$86,000.

  • Going back by year, Operating Interest Expenses was -$306,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Compugen 225.04 Mn -148.05 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -1.53 Mn
Dec 31, 2011 -1.32 Mn
API Access

Compugen Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=CGEN&period=max&api_key=YOUR_API_KEY